Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Cytokinetics Inc

NASDAQ: CYTK · Life Sciences · 8 alerts · CIK 1061983

Share price
$53.17Close, Nov 16
Market cap
$7.41B
Shares outstanding
139.3MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Cytokinetics Inc filings on SEC EDGAR ↗

4:42 PM ET Form 4
Insider Selling

Cytokinetics Insider B. Lynne Parshall Sells $274K of Stock

B. Lynne Parshall sold 5,000 shares of Cytokinetics Inc at $54.17 to $55.26 a share (average $54.73) in 2 transactions, worth $274K in total on Nov 9, 2026. Shares held after the trade: 5,784 (-30.6%).

Value
$274K
Shares
5,000
Average price
$54.73
Holding change
-30.6%
Trade date
Nov 9, 2026
4:38 PM ET Form 4
Insider Selling

Cytokinetics EVP Research & Development Fady Ibraham Malik Sells $220K of Stock

Fady Ibraham Malik, EVP Research & Development, sold 3,500 shares of Cytokinetics Inc at $62.93 a share, worth $220K in total on Nov 3, 2026. Shares held after the trade: 153,902 (-2.2%).

Value
$220K
Shares
3,500
Price
$62.93
Role
EVP Research & Development
Holding change
-2.2%
Trade date
Nov 3, 2026
6:18 PM ET Form 4
Insider Selling

Cytokinetics President & CEO Robert I. Blum Sells $471K of Stock

Robert I. Blum, President & CEO, sold 7,500 shares of Cytokinetics Inc at $62.81 a share, worth $471K in total on Nov 2, 2026. Shares held after the trade: 278,544 (-2.6%).

Value
$471K
Shares
7,500
Price
$62.81
Role
President & CEO
Holding change
-2.6%
Trade date
Nov 2, 2026
4:21 PM ET Form 4
Insider Selling

Cytokinetics EVP Research & Development Fady Ibraham Malik Sells $224K of Stock

Fady Ibraham Malik, EVP Research & Development, sold 3,500 shares of Cytokinetics Inc at $64.01 a share, worth $224K in total on Oct 20, 2026. Shares held after the trade: 153,902 (-2.2%).

Value
$224K
Shares
3,500
Price
$64.01
Role
EVP Research & Development
Holding change
-2.2%
Trade date
Oct 20, 2026
4:01 PM ET Form 4
Insider Selling

Cytokinetics President & CEO Robert I. Blum Sells $472K of Stock

Robert I. Blum, President & CEO, sold 7,500 shares of Cytokinetics Inc at $62.88 a share, worth $472K in total on Oct 12, 2026. Shares held after the trade: 278,544 (-2.6%).

Value
$472K
Shares
7,500
Price
$62.88
Role
President & CEO
Holding change
-2.6%
Trade date
Oct 12, 2026
4:25 PM ET Form 4
Insider Selling

Cytokinetics EVP Research & Development Fady Ibraham Malik Sells $215K of Stock

Fady Ibraham Malik, EVP Research & Development, sold 3,500 shares of Cytokinetics Inc at $61.38 a share, worth $215K in total on Oct 6, 2026. Shares held after the trade: 153,902 (-2.2%).

Value
$215K
Shares
3,500
Price
$61.38
Role
EVP Research & Development
Holding change
-2.2%
Trade date
Oct 6, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.